Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | PE-PGRS family protein PE_PGRS11 | 0.0028 | 0 | 0.5 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0965 | 0.5831 | 1 |
Schistosoma mansoni | 6-phosphofructokinase | 0.1636 | 1 | 1 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0028 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1636 | 1 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1636 | 1 | 1 |
Echinococcus granulosus | snurportin 1 | 0.0361 | 0.2071 | 0.2071 |
Mycobacterium leprae | conserved hypothetical protein | 0.0028 | 0 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1636 | 1 | 1 |
Mycobacterium leprae | Possible phosphoglycerate mutase | 0.0028 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0028 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0028 | 0 | 0.5 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0034 | 0.0038 | 0.0038 |
Schistosoma mansoni | hypothetical protein | 0.0361 | 0.2071 | 0.2071 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0028 | 0 | 0.5 |
Brugia malayi | Importin beta-1 subunit | 0.0034 | 0.0038 | 0.0902 |
Giardia lamblia | Hypothetical protein | 0.0965 | 0.5831 | 0.5 |
Mycobacterium leprae | PROBABLE PHOSPHOGLYCERATE MUTASE (PHOSPHOGLYCEROMUTASE) | 0.0028 | 0 | 0.5 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.1636 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1636 | 1 | 1 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0965 | 0.5831 | 1 |
Treponema pallidum | phosphoglyceromutase | 0.0028 | 0 | 0.5 |
Echinococcus granulosus | importin subunit beta 1 | 0.0034 | 0.0038 | 0.0038 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.1608 | 0.9828 | 0.9828 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0038 | 0.0038 |
Mycobacterium leprae | conserved hypothetical protein | 0.0028 | 0 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.1608 | 0.9828 | 0.9828 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.0698 | 0.4169 | 0.4169 |
Mycobacterium tuberculosis | Glucosyl-3-phosphoglycerate phosphatase GpgP | 0.0028 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0698 | 0.4169 | 0.4169 |
Mycobacterium tuberculosis | Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) | 0.0028 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0028 | 0 | 0.5 |
Chlamydia trachomatis | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase | 0.0028 | 0 | 0.5 |
Toxoplasma gondii | HEAT repeat-containing protein | 0.0034 | 0.0038 | 1 |
Brugia malayi | RNA, U transporter 1 | 0.0096 | 0.0426 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1608 | 0.9828 | 0.9828 |
Mycobacterium leprae | PROBABLE PHOSPHOGLYCERATE MUTASE 1 GPM1 (PHOSPHOGLYCEROMUTASE) (PGAM) (BPG-DEPENDENT PGAM) | 0.0028 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0698 | 0.4169 | 0.4169 |
Echinococcus multilocularis | importin subunit beta 1 | 0.0034 | 0.0038 | 0.0038 |
Mycobacterium leprae | probable isochorismate synthase EntC | 0.0028 | 0 | 0.5 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0028 | 0 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0028 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.1608 | 0.9828 | 0.9828 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1608 | 0.9828 | 0.9828 |
Echinococcus multilocularis | snurportin 1 | 0.0361 | 0.2071 | 0.2071 |
Mycobacterium tuberculosis | Probable conserved lipoprotein LpqD | 0.0028 | 0 | 0.5 |
Plasmodium falciparum | importin beta, putative | 0.0034 | 0.0038 | 1 |
Giardia lamblia | Hypothetical protein | 0.0965 | 0.5831 | 0.5 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0034 | 0.0038 | 0.0038 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0361 | 0.2071 | 0.2071 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0698 | 0.4169 | 0.4169 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0028 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1636 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0938 | 0.566 | 0.566 |
Plasmodium vivax | importin-beta 2, putative | 0.0034 | 0.0038 | 1 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0028 | 0 | 0.5 |
Mycobacterium leprae | Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) | 0.0028 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible hydrolase MutT1 | 0.0028 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible phosphoglycerate mutase Gpm2 (phosphoglyceromutase) (PGAM) (BPG-dependent PGAM) | 0.0028 | 0 | 0.5 |
Mycobacterium leprae | POSSIBLE HYDROLASE MUTT1 | 0.0028 | 0 | 0.5 |
Onchocerca volvulus | 0.1636 | 1 | 1 | |
Mycobacterium tuberculosis | Conserved protein | 0.0028 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0965 | 0.5831 | 1 |
Schistosoma mansoni | importin beta-1 | 0.0034 | 0.0038 | 0.0038 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0028 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | > 50 ug ml-1 | Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 24 hrs by agar microdilution method | ChEMBL. | 24900592 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.